RedStroke - Reducing Europe's Stroke Incidence
Launched by UNIVERSITY HOSPITAL, BASEL, SWITZERLAND · Sep 27, 2019
Trial Information
Current as of April 27, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • written informed consent
- • CHA2DS2-VASc score of 3 and above, if patients are aged under 65 years
- • CHA2DS2-VASc score of 2 and above, if patients are aged 65 years or older
- Exclusion Criteria:
- • history of Atrial Fibrillation
- • current anticoagulation treatment,
- • cardiac implanted electronic device (ICD or/and PM)
- • app cannot be installed due to technical problems (smartphone type, reduced smartphone storage capacity, other)
- • inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia, etc. of the participant
- • enrollment of the investigator, his/her family members, employees and other dependent persons
About University Hospital, Basel, Switzerland
The University Hospital Basel, Switzerland, is a leading academic medical center renowned for its commitment to cutting-edge research and innovative patient care. As a prominent clinical trial sponsor, the hospital leverages its extensive expertise and state-of-the-art facilities to advance medical knowledge and therapeutic options across various disciplines. With a collaborative approach that integrates clinical practice and scientific inquiry, the University Hospital Basel fosters an environment conducive to rigorous clinical trials, ensuring the highest standards of safety and efficacy. Its strategic focus on patient-centered research aims to translate scientific discoveries into tangible health solutions, benefiting both local and global communities.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Greifswald, Mecklenburg Vorpommern, Germany
Pasewalk, , Germany
Athens, Attica, Greece
Budapest, , Hungary
Maastricht, Limburg, Netherlands
Krakow, Lesser Poland, Poland
Basel, Basel Stadt, Switzerland
Patients applied
Trial Officials
Jens Eckstein, MD, PhD
Study Director
University Hospital, Basel, Switzerland
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials